Braskem Board Approves FY2025 Financials Revealing R$9.88 Billion Net Loss
BAK sits 72% above its 52-week low of $2.32.
Summary
Braskem's Board of Directors approved the 2025 annual financial statements, which report a significant net loss of R$9.88 billion, and called an Ordinary General Meeting to review these results and elect new board members.
Key Events · Earnings and Guidance · BAK
-
Significant Net Loss Reported
The Board approved financial statements for fiscal year 2025 revealing a net loss of R$9,879,465,238.91, which has been fully recorded under accumulated losses.
-
Ordinary General Meeting Called
An Ordinary General Meeting has been approved to review the FY2025 financial statements, management report, and to elect members of the Board of Directors and Fiscal Council.
Analysis · BAK · Industrial Applications And Services
The disclosure of a R$9.88 billion net loss for fiscal year 2025 is a highly material negative event for Braskem, as this figure significantly exceeds the company's current market capitalization. This substantial loss will be presented to shareholders at an upcoming Ordinary General Meeting, alongside proposals for the election of new Board of Directors and Fiscal Council members. Investors should closely monitor the company's strategy to address these significant accumulated losses and any potential impact on its financial stability and future operations.
At the time of this filing, BAK was trading at $4.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $2.32 to $5.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.